SCHEMBL1633943

SCHEMBL1633943

CC(C)N1CCN(c2ccc(-c3cccc4cnc(Nc5ccc(S(N)(=O)=O)cc5)nc34)cn2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 5/20 0.47
JAK2 O60674 1/20 0.45
BRD4 O60885 1/20 0.45
JUN P05412 2/20 0.44
MAPK8 P45983 1/20 0.44
IKBKB O14920 3/20 0.43
CA2 P00918 4/20 0.43
CA1 P00915 3/20 0.43
CA9 Q16790 3/20 0.43
CA12 O43570 2/20 0.43
EGFR P00533 1/20 0.43
CA4 P22748 1/20 0.42
PIK3CD O00329 1/20 0.41
AURKA O14965 1/20 0.41
DCLK1 O15075 1/20 0.41
PIK3C2G O75747 1/20 0.41
PIK3CG P48736 1/20 0.41
MAPK7 Q13164 1/20 0.41
LRRK2 Q5S007 1/20 0.41
AURKB Q96GD4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1633192 0.90 JAK2 (0.55) MAPK10JAK2BRD4JUNMAPK8
SCHEMBL1633314 0.89 MAPK10 (0.49) MAPK10JAK2BRD4JUNMAPK8
SCHEMBL1633868 0.87 MAPK10 (0.57) MAPK10JAK2JUNMAPK8CA2
SCHEMBL12724257 0.86 MAPK10 (0.46) MAPK10JAK2BRD4JUNMAPK8
SCHEMBL13498291 0.85 MAPK10 (0.46) MAPK10JAK2BRD4JUNMAPK8
SCHEMBL1635106 0.82 FGFR4 (0.47) MAPK10JAK2BRD4JUNMAPK8
SCHEMBL1632806 0.82 FGFR4 (0.47) MAPK10JAK2BRD4JUNMAPK8
SCHEMBL1632803 0.82 FGFR4 (0.47) MAPK10JAK2BRD4JUNMAPK8
SCHEMBL1633022 0.81 MAPK10 (0.44) MAPK10JAK2BRD4JUNMAPK8
SCHEMBL1632115 0.79 JAK2 (0.66) JAK2BRD4EGFRAURKACDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed